Classifications

• • C—CHEMISTRY; METALLURGY
  • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
  • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
  • C09B69/00—Dyes not provided for by a single group of this subclass
  • C09B69/10—Polymeric dyes; Reaction products of dyes with monomers or with macromolecular compounds
  • C09B69/106—Polymeric dyes; Reaction products of dyes with monomers or with macromolecular compounds containing an azo dye
• • C—CHEMISTRY; METALLURGY
  • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
  • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
  • C09B69/00—Dyes not provided for by a single group of this subclass
  • C09B69/10—Polymeric dyes; Reaction products of dyes with monomers or with macromolecular compounds
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • A61F2/02—Prostheses implantable into the body
  • A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
  • A61F2/16—Intraocular lenses
• • G—PHYSICS
  • G02—OPTICS
  • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
  • G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
  • G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics

Definitions

• the present invention relates to a process for making ocular devices with blue light absorption properties. More particularly, the present invention relates to novel yellow dyes having vinyl polymerizable groups capable of copolymerization with monomers and/or oligomers to produce copolymers useful in the manufacture of intraocular lenses or other optical devices capable of blocking blue light.
• intraocular lens intraocular lens
• an intraocular lens is implanted within an eye at the time of surgically removing the diseased or damaged natural lens, such as for example, in the case of cataracts.
• the preferred material for fabricating such intraocular lens implants was poly(methyl methacrylate), which is a rigid, glassy polymer.
• Softer, more flexible IOL implants have gained in popularity in more recent years due to their ability to be compressed, folded, rolled or otherwise deformed. Such softer IOL implants may be deformed prior to insertion thereof through an incision in the cornea of an eye.
• more flexible IOL implants as just described may be implanted into an eye through an incision that is much smaller, i.e., less than 4.0 mm, than that necessary for more rigid lOLs, i.e., 5.5 to 7.0 mm.
• a larger incision is necessary for more rigid IOL implants because the lens must be inserted through an incision in the cornea slightly larger than the diameter of the inflexible IOL optic portion. Accordingly, more rigid IOL implants have become less popular in the market since larger incisions have been found to be associated with an increased incidence of postoperative complications, such as induced astigmatism.
• Mazzocco U.S. Patent Number 4,573,998 discloses a deformable intraocular lens that can be rolled, folded or stretched to fit through a relatively small incision. The deformable lens is inserted while it is held in its distorted configuration, then released inside the chamber of the eye, whereupon the elastic property of the lens causes it to resume its molded shape.
• suitable materials for the deformable lens Mazzocco discloses polyurethane elastomers, silicone elastomers, hydrogel polymer compounds, organic or synthetic gel compounds and combinations thereof.
• Soft, foldable, high refractive index, ocular devices such as for example intraocular lenses (lOLs), capable of absorbing blue light are prepared in accordance with the present invention through the use of one or more novel reactive yellow dyes having blue light absorbing properties.
• Blue light absorbing ocular devices such as lOLs, are produced in accordance with the present invention through the copolymerization of one or more novel yellow dyes having vinyl polymerizable groups, with one or more acrylic-type monomers and/or one or more siloxane oligomers. Ocular devices so produced protect an eye's retina from potentially damaging blue light and thereby possibly provide protection from macular degeneration.
• Blue light blocking ocular devices of the present invention are produced by copolymerizing one or more novel yellow dyes having vinyl polymerizable groups with one or more acrylic-type monomers and allowing the same to undergo free radical copolymerization.
• ocular devices of the present invention may be produced by copolymerizing one or more novel yellow dyes having vinyl polymerizable groups with one or more siloxane oligomers having hydrosilane groups through a hydrosilation reaction.
• Such production processes yield ocular devices with blue light absorbing properties. By absorbing blue light, the ocular devices serve to block blue light from reaching and potentially damaging the retina of an eye implanted with the device.
• Ocular devices, such as lOLs so produced are transparent, relatively high in elongation and relatively high in refractive index.
• the present invention relates to a series of novel azo-based reactive yellow dyes useful in the production of high refractive index ocular devices such as for example but not limited to lOLs.
• Ocular devices produced using the azo-based reactive yellow dyes of the present invention have blue light absorption properties that reduce or prevent blue light from reaching the retina of an eye implanted with the ocular device.
• Azo-based reactive yellow dyes of the present invention have vinyl polymerizable groups such as for example but not limited to itaconic, fumatate, maleic, vinylacetyl, crotonic, or derivatives thereof, styrene, norbornenyi, vinyl, allyl, or like alkenyl groups.
• the azo-based reactive yellow dyes' vinyl polymerizable groups allow the same to copolymerize with acrylic-type monomers through free radical copolymerization, or with siloxane oligomers having hydrosilane groups through a hydrosilation reaction.
• Azo-based yellow dyes of the present invention have the generalized structure illustrated in Formula 1 below.
• the An groups represent the same or different, substituted or unsubstituted C 6 - 36 aromatic groups such as for example but not limited to phenyl or naphthyl, which are responsible for providing blue light absorption properties to the yellow dye;
• Ri is nothing or a straight or branched CMO alkylene spacer consisting of one or more of the atoms C, H, N, O, S, P, Si, CI or Br in any combination;
• R 2 is hydrogen or a C-M O alkyl such as for example but not limited to methyl, butyl or hexyl when m is 1 , or is nothing when m is 2;
• R 3 is nothing, a straight or branched C-M O alkylene spacer consisting of one or more of the atoms C, H, N, O, S, P, Si, CI or Br in any combination, or when R is CH 2 COOR 2 or R5 is COOR 2 , a carbonyl group;
• R 4 is hydrogen, a
• the yellow dye can be prepared by two different synthetic schemes. Both synthetic schemes involve diazotization of an aromatic amine, followed by coupling with different groups of interest depending on the desired structure of the yellow dye being synthesized. As for example, one synthetic scheme can be initiated by the reaction of N-phenyl diethanolamine with a diazonium salt of aniline, followed by a reaction with a vinyl-containing acid chloride or isocyanate to produce a reactive yellow dye. The same is further illustrated in Reaction Scheme 1 below.
• An - N N - An - N(CH 2 CH 2 OCONH-R 5 ) 2
• Another reaction scheme involves reaction of an aromatic alkylamine with a vinyl-containing acid chloride, anhydride or isocyanate to give an ethylenically unsaturated polymerizable amide or carbamate. The same is then allowed to couple with the diazonium salt of an aromatic amine to produce a yellow dye as illustrated in Reaction Scheme 2 below.
• Preferred reactive yellow dyes of the present invention useful in the manufacture of ocular devices with blue light absorbing properties include for example but are not limited to N-2-[3'-(2"-methylphenylazo)-4'- hydroxyphenyl]ethyl vinylacetamide illustrated below in Formula 2, N-2-[3'-(2"- methylphenylazo)-4'-hydroxyphenyl]ethyl maleimide illustrated below in Formula 3, N,N-bis-(2-vinylacetoxyethyl)-(4' ⁇ phenylazo)aniline illustrated below in Formula
• Reactive yellow dyes of the present invention synthesized as described above can be used in the manufacture of blue light blocking ocular devices by copolymerizing one or more of the subject reactive yellow dyes having polymerizable groups with one or more acrylic-type monomers and allowing the same to undergo free radical copolymerization.
• ocular devices of the present invention may be produced by copolymerizing one or more of the subject reactive yellow dyes having polymerizable groups with one or more siloxane oligomers having hydrosilane groups through a hydrosilation reaction using a platinum-silicone complex as a catalyst. Such production processes yield ocular devices with blue light absorbing properties.
• Reactive yellow dyes of the present invention may also be used to impart blue light absorption properties to a semi-fininshed silicone ocular device such as for example but not limited to an IOL.
• Suitable acrylic-type monomers for copolymerization with one or more reactive yellow dyes of the present invention include for example but are not limited to 2-ethylphenoxy methacrylate, 2-ethylphenoxy acrylate, 2- ethylthiophenyl methacrylate, 2-ethylthiophenyl acrylate, 2-ethylaminophenyl methacrylate, 2-ethylaminophenyl acrylate, phenyl methacrylate, benzyl methacrylate, 2-phenylethyl methacrylate, 3-phenylpropyl methacrylate, 2-(4- propylphenyl)ethyl methacrylate, 2-(4-(1-methylethyl)phenyl)ethyl methacrylate, 2-(4-methoxyphenyl)ethyl methacrylate, 2-(4-cyclohexylphenyl)
• Suitable siloxane oligomers for copolymerization with one or more reactive yellow dyes of the present invention include for example but are not limited to vinyl-capped prepolymers of high refractive index polysiloxanes such
• Step 1 Synthesis of 4-vinylacetamidoethyl phenol.
• the contents are chilled with an ice bath.
• 4.18 grams (0.04 mole) of vinylacetyl chloride is added into the flask over a period of 30 minutes.
• the ice bath is then removed and the contents are continuously stirred overnight.
• the mixture is then filtered and then condensed using a rotavapor.
• HPLC analysis indicates only one major product.
• Step 2 Coupling of product from Step 1 with toluidine diazonium salt.
• the procedure is the same as that described in U.S. Patent Number 5,470,932, Example 1 , second half except the acrylamidoethyl phenol is replaced with 4-vinylacetamidoethyl phenol.
• the product is identified by NMR and Mass Spectroscopy.
• EXAMPLE 5 Preparation of yellow dye solution for coating of an IOL: Solutions containing 1 , 2, 5 and 10 weight percent of the yellow dye of Example 4 in methylene chloride is prepared. To these solutions, platinum- cyclovinylmethylsiloxne complex (Gelest, Inc., Tullytown, Pennsylvania) at 1 % of the weight of the yellow dye is also added.
• EXAMPLE 6 Coating of Silicone Intraocular Lenses: Ten (10) freshly thermally cured SoFlexTM Model L161 U (Bausch & Lomb, Incorporated, Rochester, New York) lenses are submerged into each coating solution as described in Example 3 for 30, 60 and 120 minutes.. Takes out lenses and air dry them. Then place these lenses in an oven at 80 to 90 °C for an hour. These lenses are then subjected to standard processing to get the final finished product.
• Model LI61 U lenses are silicone lOLs derived from components consisting of a vinyl terminated polydimethyl-co-diphenyl siloxane, silicon-based reinforcing resins with vinyl groups, and an oligomer with multi hydrosilane units. Model LI61 U silicone lenses have excess free hydrosilane groups after curing
• EXAMPLE 7 Selection of Yellow Dye Concentration and Coating Conditions: Run ultraviolet (UV) and visible absorption spectroscopy of coated lenses before and after processing. Select the yellow dye concentration and residence time of lens in dye solution based on the visible light absorption of the process lenses between 400-500 nm. Conditions, which give less than 50 % transmittance and maintenance of lens power/cosmetics are chosen for further coating studies, followed by optimization of conditions.
• UV ultraviolet
• visible absorption spectroscopy of coated lenses before and after processing.
• Select the yellow dye concentration and residence time of lens in dye solution based on the visible light absorption of the process lenses between 400-500 nm.
• Conditions, which give less than 50 % transmittance and maintenance of lens power/cosmetics are chosen for further coating studies, followed by optimization of conditions.
• lOLs with blue light absorption properties are synthesized through the process of the present invention.
• Suitable catalysts for use in the process of the present invention, for a hydrosilation reaction include but are not limited to platinum (3- 3.5 %)-divinyltetramethyldisiloxane complex and platinum (3-3.5 %)- cyclovinylmethylsiloxane complex.
• the lOLs produced as described herein have the flexibility required to allow the same to be folded or deformed for insertion into an eye through the smallest possible surgical incision, i.e., 3.5 mm or smaller. It is unexpected that the subject lOLs described herein could possess the ideal physical properties disclosed herein.
• lOLs manufactured in accordance with the present invention can be of any design capable of being rolled or folded for implantation through a relatively small surgical incision, i.e., 3.5 mm or less. Such lOLs may be manufactured to have an optic portion and haptic portions made of the same or differing materials. Once the material(s) are selected, the same may be cast in molds of the desired shape, cured and removed from the molds.
• the lOLs are treated in accordance with the process of the present invention and then cleaned, polished, packaged and sterilized by customary methods known to those skilled in the art.
• the process of the present invention is also suitable for use in the production of other medical or ophthalmic devices such as contact lenses, keratoprostheses, capsular bag extension rings, corneal inlays, corneal rings and like devices.
• lOLs manufactured in accordance with the present invention are used as customary in the field of ophthalmology. For example, in a surgical cataract procedure, an incision is placed in the cornea of an eye.
• the cataractous natural lens of the eye is removed (aphakic application) and an IOL is inserted into the anterior chamber, posterior chamber or lens capsule of the eye prior to closing the incision.
• the subject ophthalmic devices may likewise be used in accordance with other surgical procedures known to those skilled in the field of ophthalmology. While there is shown and described herein a process for producing ocular devices with blue light absorption properties, it will be manifest to those skilled in the art that various modifications may be made without departing from the spirit and scope of the underlying inventive concept and that the same is not limited to particular processes and structures herein shown and described except insofar as indicated by the scope of the appended claims.

Priority Applications (4)

Applications Claiming Priority (2)

Publications (1)

Family

ID=34226569

Family Applications (1)

Country Status (9)

Cited By (1)

Families Citing this family (34)

Citations (3)

Family Cites Families (3)

• 2003
  • 2003-09-08 US US10/657,495 patent/US7098283B2/en not_active Expired - Lifetime
• 2004
  • 2004-08-19 KR KR1020067004657A patent/KR20060076767A/ko not_active Application Discontinuation
  • 2004-08-19 JP JP2006525353A patent/JP2007505170A/ja active Pending
  • 2004-08-19 WO PCT/US2004/027008 patent/WO2005026266A1/en active Search and Examination
  • 2004-08-19 CN CNA2004800257161A patent/CN1849375A/zh active Pending
  • 2004-08-19 AU AU2004272525A patent/AU2004272525A1/en not_active Abandoned
  • 2004-08-19 EP EP04781650A patent/EP1664205A1/en not_active Withdrawn
  • 2004-08-19 CA CA002536437A patent/CA2536437A1/en not_active Abandoned
  • 2004-09-07 TW TW093127062A patent/TW200526744A/zh unknown
• 2006
  • 2006-06-21 US US11/471,990 patent/US20060241263A1/en not_active Abandoned
  • 2006-06-21 US US11/472,235 patent/US7304117B2/en not_active Expired - Lifetime

Patent Citations (3)

Non-Patent Citations (4)

Also Published As

Similar Documents

Legal Events